nodes	percent_of_prediction	percent_of_DWPC	metapath
Masoprocol—LTB4R—prostate gland—urinary bladder cancer	0.0359	0.116	CbGeAlD
Masoprocol—IGF1R—prostate gland—urinary bladder cancer	0.0296	0.0954	CbGeAlD
Masoprocol—IGF1R—epithelium—urinary bladder cancer	0.0218	0.0701	CbGeAlD
Masoprocol—IGF1R—smooth muscle tissue—urinary bladder cancer	0.021	0.0675	CbGeAlD
Masoprocol—IGF1R—renal system—urinary bladder cancer	0.0202	0.065	CbGeAlD
Masoprocol—CYP2J2—prostate gland—urinary bladder cancer	0.0201	0.0647	CbGeAlD
Masoprocol—LTB4R—vagina—urinary bladder cancer	0.0177	0.0571	CbGeAlD
Masoprocol—IGF1R—female reproductive system—urinary bladder cancer	0.0162	0.0521	CbGeAlD
Masoprocol—ALOX5—prostate gland—urinary bladder cancer	0.0158	0.0509	CbGeAlD
Masoprocol—IGF1R—Idarubicin—Valrubicin—urinary bladder cancer	0.0153	0.599	CbGdCrCtD
Masoprocol—IGF1R—vagina—urinary bladder cancer	0.0146	0.0471	CbGeAlD
Masoprocol—LTB4R—lymph node—urinary bladder cancer	0.0115	0.0369	CbGeAlD
Masoprocol—ALOX5—smooth muscle tissue—urinary bladder cancer	0.0112	0.0361	CbGeAlD
Masoprocol—CYP2J2—female reproductive system—urinary bladder cancer	0.011	0.0353	CbGeAlD
Masoprocol—CYP19A1—prostate gland—urinary bladder cancer	0.0109	0.0352	CbGeAlD
Masoprocol—ALOX5—urethra—urinary bladder cancer	0.0106	0.0341	CbGeAlD
Masoprocol—CYP2J2—vagina—urinary bladder cancer	0.00992	0.0319	CbGeAlD
Masoprocol—IGF1R—lymph node—urinary bladder cancer	0.00946	0.0305	CbGeAlD
Masoprocol—ALOX5—female reproductive system—urinary bladder cancer	0.00864	0.0278	CbGeAlD
Masoprocol—CYP19A1—female reproductive system—urinary bladder cancer	0.00597	0.0192	CbGeAlD
Masoprocol—IGF1R—Idarubicin—Epirubicin—urinary bladder cancer	0.00533	0.208	CbGdCrCtD
Masoprocol—ALOX5—lymph node—urinary bladder cancer	0.00505	0.0163	CbGeAlD
Masoprocol—IGF1R—Idarubicin—Doxorubicin—urinary bladder cancer	0.00493	0.193	CbGdCrCtD
Masoprocol—CYP19A1—lymph node—urinary bladder cancer	0.00349	0.0112	CbGeAlD
Masoprocol—IGF1R—SHP2 signaling—EGFR—urinary bladder cancer	0.00174	0.00262	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways in Glioblastoma—CCND1—urinary bladder cancer	0.00168	0.00254	CbGpPWpGaD
Masoprocol—IGF1R—SHP2 signaling—KRAS—urinary bladder cancer	0.00165	0.00248	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—PTGS2—urinary bladder cancer	0.00164	0.00247	CbGpPWpGaD
Masoprocol—IGF1R—Senescence and Autophagy in Cancer—CDKN2A—urinary bladder cancer	0.00163	0.00246	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways in Glioblastoma—CDKN1A—urinary bladder cancer	0.00163	0.00245	CbGpPWpGaD
Masoprocol—IGF1R—Posttranslational regulation of adherens junction stability and dissassembly—HRAS—urinary bladder cancer	0.00163	0.00245	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways in Glioblastoma—PTEN—urinary bladder cancer	0.00162	0.00245	CbGpPWpGaD
Masoprocol—IGF1R—TSH signaling pathway—MYC—urinary bladder cancer	0.00161	0.00242	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—CXCL8—urinary bladder cancer	0.00159	0.00239	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.00157	0.00236	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways in Glioblastoma—EP300—urinary bladder cancer	0.00155	0.00233	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—IL2—urinary bladder cancer	0.00152	0.00229	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways in Glioblastoma—SRC—urinary bladder cancer	0.00151	0.00227	CbGpPWpGaD
Masoprocol—IGF1R—Senescence and Autophagy in Cancer—CXCL8—urinary bladder cancer	0.00148	0.00223	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—CCND1—urinary bladder cancer	0.00148	0.00223	CbGpPWpGaD
Masoprocol—CYP2J2—Biological oxidations—GSTP1—urinary bladder cancer	0.00146	0.0022	CbGpPWpGaD
Masoprocol—CYP2J2—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.00144	0.00217	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—MMP9—urinary bladder cancer	0.00144	0.00216	CbGpPWpGaD
Masoprocol—IGF1R—SHP2 signaling—HRAS—urinary bladder cancer	0.0014	0.00211	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.0014	0.0021	CbGpPWpGaD
Masoprocol—CYP2J2—Biological oxidations—GSTM1—urinary bladder cancer	0.00134	0.00202	CbGpPWpGaD
Masoprocol—IGF1R—Senescence and Autophagy in Cancer—CDKN1A—urinary bladder cancer	0.00134	0.00201	CbGpPWpGaD
Masoprocol—IGF1R—Senescence and Autophagy in Cancer—PTEN—urinary bladder cancer	0.00133	0.00201	CbGpPWpGaD
Masoprocol—IGF1R—Apoptosis—MYC—urinary bladder cancer	0.00132	0.00199	CbGpPWpGaD
Masoprocol—CYP2J2—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.00132	0.00199	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways in Glioblastoma—EGFR—urinary bladder cancer	0.00132	0.00199	CbGpPWpGaD
Masoprocol—IGF1R—TSH signaling pathway—HRAS—urinary bladder cancer	0.00126	0.0019	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways in Glioblastoma—KRAS—urinary bladder cancer	0.00125	0.00188	CbGpPWpGaD
Masoprocol—CYP19A1—Biological oxidations—NAT2—urinary bladder cancer	0.00125	0.00188	CbGpPWpGaD
Masoprocol—IGF1R—Senescence and Autophagy in Cancer—SRC—urinary bladder cancer	0.00124	0.00186	CbGpPWpGaD
Masoprocol—CYP19A1—FSH signaling pathway—SRC—urinary bladder cancer	0.00123	0.00186	CbGpPWpGaD
Masoprocol—IGF1R—MicroRNAs in cardiomyocyte hypertrophy—TNF—urinary bladder cancer	0.00123	0.00186	CbGpPWpGaD
Masoprocol—IGF1R—Apoptosis—TNF—urinary bladder cancer	0.00123	0.00186	CbGpPWpGaD
Masoprocol—CYP19A1—Metapathway biotransformation—NAT2—urinary bladder cancer	0.00123	0.00185	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—MYC—urinary bladder cancer	0.00119	0.00179	CbGpPWpGaD
Masoprocol—IGF1R—IRS-related events triggered by IGF1R—KRAS—urinary bladder cancer	0.00117	0.00176	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—EGFR—urinary bladder cancer	0.00116	0.00175	CbGpPWpGaD
Masoprocol—ALOX5—Selenium Micronutrient Network—PTGS2—urinary bladder cancer	0.00115	0.00173	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—IGF1—urinary bladder cancer	0.00115	0.00173	CbGpPWpGaD
Masoprocol—IGF1R—IGF1R signaling cascade—KRAS—urinary bladder cancer	0.00114	0.00171	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways in Glioblastoma—TP53—urinary bladder cancer	0.00111	0.00167	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—TNF—urinary bladder cancer	0.00111	0.00166	CbGpPWpGaD
Masoprocol—IGF1R—Apoptosis—TP53—urinary bladder cancer	0.00109	0.00164	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways in Glioblastoma—HRAS—urinary bladder cancer	0.00106	0.0016	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—RHOA—urinary bladder cancer	0.00105	0.00158	CbGpPWpGaD
Masoprocol—CYP19A1—Biological oxidations—HPGDS—urinary bladder cancer	0.000996	0.0015	CbGpPWpGaD
Masoprocol—IGF1R—IRS-related events triggered by IGF1R—HRAS—urinary bladder cancer	0.000993	0.0015	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—TSC1—urinary bladder cancer	0.000986	0.00148	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—TP53—urinary bladder cancer	0.000974	0.00147	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—ERBB2—urinary bladder cancer	0.000973	0.00146	CbGpPWpGaD
Masoprocol—IGF1R—IGF1R signaling cascade—HRAS—urinary bladder cancer	0.000967	0.00146	CbGpPWpGaD
Masoprocol—CYP19A1—Biological oxidations—GSTT1—urinary bladder cancer	0.000966	0.00146	CbGpPWpGaD
Masoprocol—IGF1R—Insulin Signaling—PTEN—urinary bladder cancer	0.000952	0.00143	CbGpPWpGaD
Masoprocol—IGF1R—Senescence and Autophagy in Cancer—TP53—urinary bladder cancer	0.00091	0.00137	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—GSTZ1—urinary bladder cancer	0.000894	0.00135	CbGpPWpGaD
Masoprocol—IGF1R—Senescence and Autophagy in Cancer—HRAS—urinary bladder cancer	0.00087	0.00131	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—CCND1—urinary bladder cancer	0.000859	0.00129	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—GSTO2—urinary bladder cancer	0.000847	0.00128	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—NAT1—urinary bladder cancer	0.000847	0.00128	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000833	0.00126	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—PTEN—urinary bladder cancer	0.000829	0.00125	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—HDAC4—urinary bladder cancer	0.000821	0.00124	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—GSTZ1—urinary bladder cancer	0.000797	0.0012	CbGpPWpGaD
Masoprocol—ALOX5—Selenium Micronutrient Network—TNF—urinary bladder cancer	0.000777	0.00117	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—UGT2B7—urinary bladder cancer	0.000775	0.00117	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—SRC—urinary bladder cancer	0.000769	0.00116	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—GSTO2—urinary bladder cancer	0.000755	0.00114	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—NAT1—urinary bladder cancer	0.000755	0.00114	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000743	0.00112	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—CXCL8—urinary bladder cancer	0.000728	0.0011	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000719	0.00108	CbGpPWpGaD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—urinary bladder cancer	0.000718	0.00108	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—HDAC4—urinary bladder cancer	0.000698	0.00105	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CYP4B1—urinary bladder cancer	0.000698	0.00105	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—UGT2B7—urinary bladder cancer	0.000691	0.00104	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—GLI1—urinary bladder cancer	0.000688	0.00104	CbGpPWpGaD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—urinary bladder cancer	0.000678	0.00102	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—EGFR—urinary bladder cancer	0.000674	0.00102	CbGpPWpGaD
Masoprocol—CYP19A1—Biological oxidations—GSTP1—urinary bladder cancer	0.00067	0.00101	CbGpPWpGaD
Masoprocol—CYP19A1—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000661	0.000995	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—SLC19A1—urinary bladder cancer	0.000659	0.000993	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PRSS3—urinary bladder cancer	0.000642	0.000967	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CYP4B1—urinary bladder cancer	0.000622	0.000937	CbGpPWpGaD
Masoprocol—IGF1R—Insulin Signaling—HRAS—urinary bladder cancer	0.000621	0.000936	CbGpPWpGaD
Masoprocol—CYP19A1—Biological oxidations—GSTM1—urinary bladder cancer	0.000616	0.000927	CbGpPWpGaD
Masoprocol—CYP19A1—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000607	0.000915	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—SLC19A1—urinary bladder cancer	0.000587	0.000885	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—GLI1—urinary bladder cancer	0.000585	0.000881	CbGpPWpGaD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—urinary bladder cancer	0.000577	0.000869	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PRSS3—urinary bladder cancer	0.000572	0.000862	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—CXCL8—urinary bladder cancer	0.000554	0.000835	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—HRAS—urinary bladder cancer	0.000541	0.000815	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—ATM—urinary bladder cancer	0.000541	0.000815	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—CDK4—urinary bladder cancer	0.000539	0.000812	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—ESR1—urinary bladder cancer	0.000537	0.000808	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.000515	0.000776	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—TYMP—urinary bladder cancer	0.000513	0.000773	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.000493	0.000743	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—RBX1—urinary bladder cancer	0.000471	0.00071	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—RB1—urinary bladder cancer	0.000469	0.000706	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—CDH1—urinary bladder cancer	0.000467	0.000703	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—NAT2—urinary bladder cancer	0.000464	0.000699	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.000459	0.000691	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—TYMP—urinary bladder cancer	0.000458	0.000689	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—TSC1—urinary bladder cancer	0.000443	0.000668	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.000439	0.000662	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—JAG1—urinary bladder cancer	0.000422	0.000636	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—NAT2—urinary bladder cancer	0.000414	0.000623	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GSTZ1—urinary bladder cancer	0.00041	0.000618	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—RBX1—urinary bladder cancer	0.000401	0.000604	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—RRM2—urinary bladder cancer	0.000401	0.000604	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—NAT1—urinary bladder cancer	0.000389	0.000586	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GSTO2—urinary bladder cancer	0.000389	0.000586	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000383	0.000576	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—TSC1—urinary bladder cancer	0.000377	0.000568	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—HPGDS—urinary bladder cancer	0.000371	0.000559	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—ENO2—urinary bladder cancer	0.000371	0.000559	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	0.000369	0.000556	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—GSTT1—urinary bladder cancer	0.00036	0.000542	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—JAG1—urinary bladder cancer	0.000359	0.00054	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—RRM2—urinary bladder cancer	0.000357	0.000538	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—RHOA—urinary bladder cancer	0.000357	0.000537	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—UGT2B7—urinary bladder cancer	0.000356	0.000536	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	0.000354	0.000534	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—CCND1—urinary bladder cancer	0.000348	0.000524	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—S100B—urinary bladder cancer	0.000342	0.000515	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—PTEN—urinary bladder cancer	0.000336	0.000506	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ENO2—urinary bladder cancer	0.000331	0.000498	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—HPGDS—urinary bladder cancer	0.000331	0.000498	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	0.000329	0.000495	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—RHOA—urinary bladder cancer	0.000324	0.000488	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—GSTT1—urinary bladder cancer	0.000321	0.000483	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CYP4B1—urinary bladder cancer	0.00032	0.000483	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—EP300—urinary bladder cancer	0.00032	0.000483	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	0.000316	0.000476	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—CXCL8—urinary bladder cancer	0.000313	0.000472	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—NCOR1—urinary bladder cancer	0.000307	0.000463	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—SLC19A1—urinary bladder cancer	0.000303	0.000456	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—IL2—urinary bladder cancer	0.000299	0.000451	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—NQO1—urinary bladder cancer	0.000299	0.000451	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PRSS3—urinary bladder cancer	0.000295	0.000444	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—S100B—urinary bladder cancer	0.00029	0.000438	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	0.00029	0.000437	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—CXCL8—urinary bladder cancer	0.000284	0.000428	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—MYC—urinary bladder cancer	0.000279	0.00042	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—EGFR—urinary bladder cancer	0.000273	0.000411	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—IL2—urinary bladder cancer	0.000272	0.000409	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—TERT—urinary bladder cancer	0.000271	0.000408	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—NQO1—urinary bladder cancer	0.000267	0.000402	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—NCOR1—urinary bladder cancer	0.000261	0.000393	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	0.000259	0.00039	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—KRAS—urinary bladder cancer	0.000258	0.000389	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	0.000253	0.000381	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—GSTP1—urinary bladder cancer	0.000249	0.000376	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—FGFR3—urinary bladder cancer	0.000248	0.000374	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	0.000241	0.000364	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—ESR1—urinary bladder cancer	0.000241	0.000363	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.000236	0.000356	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—TYMP—urinary bladder cancer	0.000236	0.000355	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—TYMS—urinary bladder cancer	0.000232	0.000349	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—TERT—urinary bladder cancer	0.00023	0.000347	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—NCOR1—urinary bladder cancer	0.000229	0.000345	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—GSTM1—urinary bladder cancer	0.000229	0.000345	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—TP53—urinary bladder cancer	0.000229	0.000345	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.000226	0.000341	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	0.000226	0.00034	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—GSTP1—urinary bladder cancer	0.000222	0.000335	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—GPX1—urinary bladder cancer	0.00022	0.000331	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—ERCC2—urinary bladder cancer	0.000216	0.000325	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	0.000215	0.000324	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—NAT2—urinary bladder cancer	0.000213	0.000321	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CREBBP—urinary bladder cancer	0.000211	0.000319	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—FGFR3—urinary bladder cancer	0.000211	0.000318	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—IGF1—urinary bladder cancer	0.000209	0.000315	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—EGFR—urinary bladder cancer	0.000208	0.000313	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—TYMS—urinary bladder cancer	0.000207	0.000311	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—ESR1—urinary bladder cancer	0.000205	0.000309	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—GSTM1—urinary bladder cancer	0.000204	0.000308	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—NCOR1—urinary bladder cancer	0.000204	0.000308	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—MTHFR—urinary bladder cancer	0.000203	0.000305	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—KRAS—urinary bladder cancer	0.000196	0.000296	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—GPX1—urinary bladder cancer	0.000196	0.000295	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ERCC2—urinary bladder cancer	0.000192	0.000289	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—RHOA—urinary bladder cancer	0.000191	0.000288	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—RRM2—urinary bladder cancer	0.000184	0.000277	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—MTHFR—urinary bladder cancer	0.000181	0.000272	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CREBBP—urinary bladder cancer	0.00018	0.000271	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—IGF1—urinary bladder cancer	0.000178	0.000268	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—ERBB2—urinary bladder cancer	0.000177	0.000267	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—HPGDS—urinary bladder cancer	0.00017	0.000257	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ENO2—urinary bladder cancer	0.00017	0.000257	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	0.000169	0.000255	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CXCL8—urinary bladder cancer	0.000168	0.000253	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—HRAS—urinary bladder cancer	0.000167	0.000251	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GSTT1—urinary bladder cancer	0.000165	0.000249	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PPARG—urinary bladder cancer	0.000164	0.000248	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	0.000163	0.000245	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—RHOA—urinary bladder cancer	0.000163	0.000245	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—IL2—urinary bladder cancer	0.000161	0.000242	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CREBBP—urinary bladder cancer	0.000158	0.000238	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CCND1—urinary bladder cancer	0.000156	0.000236	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—MMP9—urinary bladder cancer	0.000152	0.000229	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CDKN1A—urinary bladder cancer	0.000151	0.000228	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PTEN—urinary bladder cancer	0.000151	0.000228	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—ERBB2—urinary bladder cancer	0.000151	0.000227	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PPARG—urinary bladder cancer	0.000146	0.000221	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—EP300—urinary bladder cancer	0.000144	0.000217	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CXCL8—urinary bladder cancer	0.000143	0.000215	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CREBBP—urinary bladder cancer	0.000141	0.000212	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—SRC—urinary bladder cancer	0.00014	0.000211	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—NQO1—urinary bladder cancer	0.000137	0.000207	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—IL2—urinary bladder cancer	0.000136	0.000206	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	0.000133	0.000201	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CCND1—urinary bladder cancer	0.000133	0.0002	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PTGS2—urinary bladder cancer	0.000129	0.000195	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—MMP9—urinary bladder cancer	0.000129	0.000195	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CDKN1A—urinary bladder cancer	0.000129	0.000194	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PTEN—urinary bladder cancer	0.000128	0.000193	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—MYC—urinary bladder cancer	0.000126	0.000189	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—EGFR—urinary bladder cancer	0.000123	0.000185	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—EP300—urinary bladder cancer	0.000122	0.000184	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—SRC—urinary bladder cancer	0.000119	0.000179	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	0.000116	0.000175	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—KRAS—urinary bladder cancer	0.000116	0.000175	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PTGS2—urinary bladder cancer	0.000115	0.000174	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GSTP1—urinary bladder cancer	0.000115	0.000173	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PTEN—urinary bladder cancer	0.000113	0.00017	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	0.000111	0.000167	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—EP300—urinary bladder cancer	0.000108	0.000162	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—MYC—urinary bladder cancer	0.000107	0.000161	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—TYMS—urinary bladder cancer	0.000107	0.00016	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—NCOR1—urinary bladder cancer	0.000105	0.000159	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GSTM1—urinary bladder cancer	0.000105	0.000159	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—EGFR—urinary bladder cancer	0.000104	0.000157	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—TP53—urinary bladder cancer	0.000103	0.000155	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GPX1—urinary bladder cancer	0.000101	0.000152	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PTEN—urinary bladder cancer	0.0001	0.000151	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ERCC2—urinary bladder cancer	9.9e-05	0.000149	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—KRAS—urinary bladder cancer	9.86e-05	0.000149	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—HRAS—urinary bladder cancer	9.86e-05	0.000148	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—EP300—urinary bladder cancer	9.58e-05	0.000144	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—MTHFR—urinary bladder cancer	9.3e-05	0.00014	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—TP53—urinary bladder cancer	8.76e-05	0.000132	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—HRAS—urinary bladder cancer	8.38e-05	0.000126	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PPARG—urinary bladder cancer	7.54e-05	0.000114	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CREBBP—urinary bladder cancer	7.25e-05	0.000109	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PTGS2—urinary bladder cancer	5.93e-05	8.94e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PTEN—urinary bladder cancer	5.18e-05	7.8e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—EP300—urinary bladder cancer	4.94e-05	7.44e-05	CbGpPWpGaD
